158 related articles for article (PubMed ID: 34539981)
41. CD169
Batoon L; Millard SM; Wullschleger ME; Preda C; Wu AC; Kaur S; Tseng HW; Hume DA; Levesque JP; Raggatt LJ; Pettit AR
Biomaterials; 2019 Mar; 196():51-66. PubMed ID: 29107337
[TBL] [Abstract][Full Text] [Related]
42. CD169
Perez OA; Yeung ST; Vera-Licona P; Romagnoli PA; Samji T; Ural BB; Maher L; Tanaka M; Khanna KM
Sci Immunol; 2017 Oct; 2(16):. PubMed ID: 28986418
[TBL] [Abstract][Full Text] [Related]
43. TLR7 Controls VSV Replication in CD169
Solmaz G; Puttur F; Francozo M; Lindenberg M; Guderian M; Swallow M; Duhan V; Khairnar V; Kalinke U; Ludewig B; Clausen BE; Wagner H; Lang KS; Sparwasser TD
Front Immunol; 2019; 10():466. PubMed ID: 30930901
[TBL] [Abstract][Full Text] [Related]
44. CD169/SIGLEC1 is expressed on circulating monocytes in COVID-19 and expression levels are associated with disease severity.
Doehn JM; Tabeling C; Biesen R; Saccomanno J; Madlung E; Pappe E; Gabriel F; Kurth F; Meisel C; Corman VM; Hanitsch LG; Treskatsch S; Heim K; Stegemann MS; Ruwwe-Glösenkamp C; Müller-Redetzky HC; Uhrig A; Somasundaram R; Spies C; von Bernuth H; Hofmann J; Drosten C; Suttorp N; Witzenrath M; Sander LE; Hübner RH
Infection; 2021 Aug; 49(4):757-762. PubMed ID: 33825125
[TBL] [Abstract][Full Text] [Related]
45. Intestinal CD169(+) macrophages initiate mucosal inflammation by secreting CCL8 that recruits inflammatory monocytes.
Asano K; Takahashi N; Ushiki M; Monya M; Aihara F; Kuboki E; Moriyama S; Iida M; Kitamura H; Qiu CH; Watanabe T; Tanaka M
Nat Commun; 2015 Jul; 6():7802. PubMed ID: 26193821
[TBL] [Abstract][Full Text] [Related]
46. Fc chimeric protein containing the cysteine-rich domain of the murine mannose receptor binds to macrophages from splenic marginal zone and lymph node subcapsular sinus and to germinal centers.
Martínez-Pomares L; Kosco-Vilbois M; Darley E; Tree P; Herren S; Bonnefoy JY; Gordon S
J Exp Med; 1996 Nov; 184(5):1927-37. PubMed ID: 8920880
[TBL] [Abstract][Full Text] [Related]
47. The antigen recognized by MOMA-I is sialoadhesin.
Oetke C; Kraal G; Crocker PR
Immunol Lett; 2006 Jul; 106(1):96-8. PubMed ID: 16716409
[TBL] [Abstract][Full Text] [Related]
48. CD169 Expression in Lymph Nodes is Associated with Increased Infiltration of CD8
Wang Y; Wu XT; Chen J
J Immunol Res; 2024; 2024():8873767. PubMed ID: 38250298
[TBL] [Abstract][Full Text] [Related]
49. Sialoadhesin on macrophages: its identification as a lymphocyte adhesion molecule.
van den Berg TK; Brevé JJ; Damoiseaux JG; Döpp EA; Kelm S; Crocker PR; Dijkstra CD; Kraal G
J Exp Med; 1992 Sep; 176(3):647-55. PubMed ID: 1512534
[TBL] [Abstract][Full Text] [Related]
50. Expression of macrophage/dendritic cell-related molecules in lymph node sinus macrophages.
Yamada R; Ohnishi K; Pan C; Yano H; Fujiwara Y; Shiota T; Mikami Y; Komohara Y
Microbiol Immunol; 2023 Nov; 67(11):490-500. PubMed ID: 37622582
[TBL] [Abstract][Full Text] [Related]
51. CD169
Shaabani N; Duhan V; Khairnar V; Gassa A; Ferrer-Tur R; Häussinger D; Recher M; Zelinskyy G; Liu J; Dittmer U; Trilling M; Scheu S; Hardt C; Lang PA; Honke N; Lang KS
Cell Death Dis; 2016 Nov; 7(11):e2446. PubMed ID: 27809306
[TBL] [Abstract][Full Text] [Related]
52. SCS macrophages suppress melanoma by restricting tumor-derived vesicle-B cell interactions.
Pucci F; Garris C; Lai CP; Newton A; Pfirschke C; Engblom C; Alvarez D; Sprachman M; Evavold C; Magnuson A; von Andrian UH; Glatz K; Breakefield XO; Mempel TR; Weissleder R; Pittet MJ
Science; 2016 Apr; 352(6282):242-6. PubMed ID: 26989197
[TBL] [Abstract][Full Text] [Related]
53. Increased Expression of CD169 on Blood Monocytes and Its Regulation by Virus and CD8 T Cells in Macaque Models of HIV Infection and AIDS.
Kim WK; McGary CM; Holder GE; Filipowicz AR; Kim MM; Beydoun HA; Cai Y; Liu X; Sugimoto C; Kuroda MJ
AIDS Res Hum Retroviruses; 2015 Jul; 31(7):696-706. PubMed ID: 25891017
[TBL] [Abstract][Full Text] [Related]
54. The effect of targeted delivery of anti-TNF-α oligonucleotide into CD169+ macrophages on disease progression in lupus-prone MRL/lpr mice.
Huang Z; Zhang Z; Zha Y; Liu J; Jiang Y; Yang Y; Shao J; Sun X; Cai X; Yin Y; Chen J; Dong L; Zhang J
Biomaterials; 2012 Oct; 33(30):7605-12. PubMed ID: 22795853
[TBL] [Abstract][Full Text] [Related]
55. Splenic CD163
Yuste M; Fernández-Caballero T; Prieto C; Álvarez B; Martínez-Lobo J; Simarro I; Castro JM; Alonso F; Ezquerra Á; Domínguez J; Revilla C
Vet Microbiol; 2017 Jan; 198():72-80. PubMed ID: 28062010
[TBL] [Abstract][Full Text] [Related]
56. Mouse sialoadhesin is not responsible for Candida albicans yeast cell binding to splenic marginal zone macrophages.
Han Y; Kelm S; Riesselman MH; Crocker PR; Cutler JE
Infect Immun; 1994 May; 62(5):2115-8. PubMed ID: 8168979
[TBL] [Abstract][Full Text] [Related]
57. Optimization of Liposomes for Antigen Targeting to Splenic CD169
Nijen Twilhaar MK; Czentner L; Grabowska J; Affandi AJ; Lau CYJ; Olesek K; Kalay H; van Nostrum CF; van Kooyk Y; Storm G; Haan JMMD
Pharmaceutics; 2020 Nov; 12(12):. PubMed ID: 33255564
[TBL] [Abstract][Full Text] [Related]
58. Polymorphisms in SIGLEC1 contribute to susceptibility to pulmonary active tuberculosis possibly through the modulation of IL-1ß.
Souza de Lima D; Nunes VCL; Ogusku MM; Sadahiro A; Pontillo A; Alencar BC
Infect Genet Evol; 2017 Nov; 55():313-317. PubMed ID: 28964857
[TBL] [Abstract][Full Text] [Related]
59. Maf expression in human macrophages and lymph node sinus macrophages in patients with esophageal cancer.
Takeya H; Ohnishi K; Shiota T; Saito Y; Fujiwara Y; Yagi T; Kiyozumi Y; Baba Y; Yoshida N; Asano K; Tanaka M; Baba H; Komohara Y
J Clin Exp Hematop; 2019; 59(3):112-118. PubMed ID: 31564713
[TBL] [Abstract][Full Text] [Related]
60. MiR-195-5p inhibits the development of chronic obstructive pulmonary disease via targeting siglec1.
Li S; Jiang L; Yang Y; Cao J; Zhang Q; Zhang J; Wang R; Deng X; Li Y
Hum Exp Toxicol; 2020 Oct; 39(10):1333-1344. PubMed ID: 32351126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
